A single immunization with a plasmid encoding hepatitis C virus (HCV) structural proteins under the elongation factor 1-α promoter elicits HCV- specific cytotoxic T-lymphocytes (CTL)

Vaccine

Volumn 18, Issue 7-8, 1999, Pages 675-680

  Nishimura, Yuki ^a   Kamei, Akira ^a   Uno Furuta, Satori ^a   Tamaki, Shigenori ^a   Kim, Gisen ^a   Adachi, Yukihiko ^a   Kuribayashi, Kagemasa ^a   Matsuura, Yoshiharu ^b   Miyamura, Tatsuo ^b   Yasutomi, Yasuhiro ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

CTL; DNA vaccine; HCV

Indexed keywords

DNA VACCINE; ELONGATION FACTOR 1ALPHA; STRUCTURAL PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS NON A NON B; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; CYTOMEGALOVIRUS; CYTOTOXICITY, IMMUNOLOGIC; DNA, VIRAL; HEPACIVIRUS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE ELONGATION FACTOR 1; PLASMIDS; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL HEPATITIS VACCINES; VIRAL STRUCTURAL PROTEINS;

EID: 0032709309     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00270-4     Document Type: Article

References (45)

1. Choo Q.-L., Kuo G., Weiner A., Overby L.R., Brady D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
2. Houghton M., Weiner A., Han J., Kuo G., Choo Q.-L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 14:1991;381-388.
3. Kuo G., Choo Q.-L., Alter H., Gitnick G., Redeker A., Purcel R., Miyamura T., Dienstag J., Alter M., Stevens C., Tegtmeier G., Bonino F., Colombo M., Lee W.-S., Kuo G., Berger K., Shuster J., Overby L., Bradley D., Houghton M. An assay for circulating antibodies to major etiologic form human non-A, non-B hepatitis. Science. 244:1989;362-364.
4. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y., Choo Q.-L., Houghton M., Kuo G. Hepatitis C virus infection is associated with development of hepatcellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6547-6549.
5. Nelson D.R., Marousis C.G., Davis G.L., Rice C.M., Wong J., Houghton M., Lau J.Y.N. The role of hepatitis C virus-specific cytotoxic T-lymphocytes in chronic hepatitis C. J. Immunol. 158:1997;1473-1481.
6. Mochizuki K., Hayashi N., Kitayama K., Hiramatsu N., Kanto T., Mita E., Tatsumi T., Kuzushita T., Kasahara A., Fusamoto H., Yokochi T., Kamada T. B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C. Hepatology. 25:1997;713-718.
7. Makimura M., Miyatake S., Akino N., Takamori K., Matsuura Y., Miyamura T., Saito I. Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus. Vaccine. 14:1996;28-34.
8. Bruna-Romero O., Lasarte J.J., Wilkinson G., Grace K., Clarke B., Borras-Cuesta F., Prieto J. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus. Hepatology. 25:1997;470-477.
9. Cox G.J.M., Zamb T.J., Babiuk L.A. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67:1993;5664-5667.
10. Donnely J.I., Friedman A., Martinez D., Montgomery D.L., Shiver J.W., Motzel S.L., Ulmer J.B., Liu M.A. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat. Med. 1:1995;583-587.
11. Fynann E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunization by parental, mucosal and gene-gun inoculations. Proc. Natl. Acad. Sci. USA. 90:1993;11478-11482.
12. Manickan E.R., Rouse R.J.D., Yu Z., Wire W.S., Rouse B.T. Genetic immunization against herpes simplex virus. J. Immunol. 155:1995;259-265.
13. Robinson H.L., Felquate D.M., Webster R.G. Protection against a lethal influenza virus challenge by immunization with a hemagglutin-expressing plasmid DNA. Vaccine. 11:1993;957-960.
14. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., Dewitt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry J.W., Shiver J.W., Montgomery D.L., Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
15. Webster R.G., Fynan E.F., Santoro J.C., Robinson H. Protection of ferrets against influenza challenge with a DNA vaccine to the haemaglitinin. Vaccine. 12:1994;1495-1498.
16. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Chen J., Ertl H.C.J. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology. 199:1994;132-140.
17. Letvin N.L., Montefiori D.C., Yasutomi Y., Perry H.C., Davies M-E., Lekutis C., Alroy M., Freed D.C., Lord C.I., Handt L.K., Liu M.A., Shiver J.W. Potent protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. USA. 94:1997;9378-9383.
18. Michel M.-L., Davis H.L., Schleef M., Mancini M., Tiollais P., Whalen R.G. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA. 92:1995;5307-5311.
19. Tang D., De Vit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
20. Yankauckas M.A., Morrow J.E., Parker S.E., Abai A., Rhodes G.H., Dwarki V.J., Gromkowski S.H. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biol. 12:1993;771-776.
21. Lu S., Arthos J., Montefiori D.C., Yasutomi Y., Manson K., Mustafa F., Johnson E., Santoro J.C., Wissink J., Mullins J.I., Haynes J.R., Letvin N.L., Wyand M., Robinson H.L. Simian immunodeficiency virus DNA vaccine trial in macaques. J. Virol. 70:1996;3978-3991.
22. Slobin L.I. The role of eukaryotic factor Tu in protein synthesis: the measurement of the elongation factor Tu content of rabbit reticulocyte and other mammalian cells by a sensitive radioimmunoassay. Eur. J. Biochem. 110:1980;555-563.
23. Kim D.W., Uetsuki T., Kaziro T., Yamaguchi N., Sugano S. Use of the human elongation factor 1α promoter as a versatile and efficient expression system. Gene. 91:1990;217-223.
24. Matsuura Y., Suzuki T., Suzuki R., Satho M., Aizaki H., Saito I., Miyamura T. Processing of E1 and E2 glycoproteins of HCV expressed in insect and mammalian cells. Virology. 205:1994;141-150.
25. Kim D.W., Harada T., Saito I., Miyamura T. An efficient expression vector for stable expression in human liver cells. Gene. 134:1993;307-308.
26. Tokushige T., Moradpour D., Wakita T., Geissler M., Hayashi N., Wands J.R. Comparison between cytomegarovirus promoter and elongation factor-1α promoter-driven constructs in the establishment of cell lines expressing hepatitis C virus core protein. J. Virol. Methods. 64:1997;73-80.
27. Shirai M., Okada H., Nishioka M., Akatsuka T., Wychowsky C., Houghten R., Pendleton C.D., Firestone S.M., Berzofsky J.A. An epitope in hepatitis C virus core region recognized by cytotoxic T-cells in mice and humans. J. Virol. 68:1994;3334-3342.
28. Van Snick J., Maryanski J., Van Pel A., Parmiani G., Boon T. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associatively of variant-specific antigens. Eur. J. Immunol. 12:1982;905-912.
29. Ada G.L. The immunological basis of vaccine development. Semin. Virol. Ser. 1:1990;3-11.
30. Morrison L.A., Lukacher A.E., Braciale V.L., Fan D.P., Braciale T.J. Differences in antigen presentation to MHC class I and class II-restricted influenza virus-specific cytotoxic T-lymphocyte clones. J. Exp. Med. 163:1986;903-915.
31. Raz E., Carson D.A., Parker S.E., Parr T.B., Abai A.M., Archinger G., Gromkowski S.J., Malini S., Lew D., Yankaucks M.A., Baird S.M., Rhodes G.H. Interdermalgene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA. 91:1994;9519-9523.
32. Yokoyama M., Zhang J., Whitton J.L. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:1995;2684-2688.
33. Zarozinski C.C., Fynan E.F., Selin L.K., Robinson H.L., Welsh R.M. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154:1995;4010-4017.
34. Tokushige K., Wakita T., Pachuck C., Moradopore D., Weiner D.B., Zurawski V.R., Wands J.R. Expression and immune responses to hepatitis C virus core DNA-based vaccine constructs. Hepatology. 24:1996;14-20.
35. Saito T., Sherman G.J., Kurokouchi K., Guo Z.-P., Donets M., Yu M.-Y.W., Berzofsky J.A., Akatsuka T., Feinstone S. Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice. Gastroenterology. 112:1997;1321-1330.
36. Encke J., Putlitz J.Z., Geissler M., Wands J.R. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J. Immunol. 161:1998;4917-4923.
37. Hiranuma K., Tamaki S., Nishimura Y., Kusuki S., Isogawa M., Kim G., Kaito M., Kuribayashi K., Adachi Y., Yasutomi Y. Helper T-cell determinant peptide contributes to induction of cellular immune responses by peptide vaccine against hepatitis C virus. J. Gen. Virol. 80:1999;187-193.
38. Horspool J.H., Perrin P.J., Woodcock J.B., Cox J.H., King C.L., June C.H., Harlan D.M., St. Louis D.C., Lee K.P. Nucleic acid vaccine-induced immune responses require CD28 costimulation are regulated by CTLA4. J. Immunol. 160:1998;2706-2714.
39. Gleissler M., Geisien A., Wands J.R. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmid. J. Immunol. 159:1997;5107-5113.
40. Geissler M., Geisien A., Tokushige K., Wands J.R. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J. Immunol. 158:1997;1231-1237.
41. Uetsuki T., Naito A., Nagata S., Kaziro Y. Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor 1α J. Biochem. 264:1989;5791-5798.
42. Wakabayashi-Ito N., Nagata S. Characterization of the regulatory elements in the promoter of the human elongation factor-1α gene. J. Biochem. 269:1994;29831-29837.
43. Ruggieri A., Harada T., Matsuura Y., Miyamura T. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology. 229:1997;68-76.
44. Liu M.A., Yasutomi Y., Davis M.E., Perry H.C., Freed D.C., Letvin N.L., Shiver J.W. Vaccination of mice and non-human primates using HIV-gene-containing DNA. Antibiot. Chemother. 48:1996;100-104.
45. Yasutomi Y., Robinson H.L., Lu S., Mustafa F., Lekutis C., Arthos J., Mullins J.I., Voss G., Manson K., Wyand M., Letvin N.L. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J. Virol. 70:1996;678-681.